FIELD: medicine.
SUBSTANCE: method involves dividing cells by using agglutination. Required reagents comprise dextrane solution, anti-Glycophorin A-antibody, anti-CD15-antibody, anti-CD9-antibody, and antibodies selected from a group composed of anti-CD3-antibody, anti-CD72-antibody, anti-CD16-antibody, anti-CD4-antibody, anti-CD8-antibody and anti-CD2-antibody.
EFFECT: enhanced effectiveness in selecting blood cells of rare cell types with high output amount.
33 cl, 17 tbl
Authors
Dates
2007-01-27—Published
2002-03-07—Filed